On Tuesday, October 13, Johnson & Johnson JNJ will release its latest earnings report. Here is Benzinga's outlook for the company.
Earnings and Revenue
Based on management's projections, Johnson & Johnson analysts model for earnings of $1.96 per share on sales of $20.13 billion. In the same quarter last year, Johnson & Johnson reported EPS of $2.12 on revenue of $20.73 billion. If the company were to match the consensus estimate when it reports Tuesday, earnings would be down 7.55%. Revenue would be down 2.89% from the same quarter last year. Here is how the company's reported EPS has stacked up against analyst estimates in the past:
Quarter | Q2 2020 | Q1 2020 | Q4 2020 | Q3 2019 |
---|---|---|---|---|
EPS Estimate | 1.48 | 1.99 | 1.87 | 2 |
EPS Actual | 1.67 | 2.30 | 1.88 | 2.12 |
Revenue Estimate | 17.50 B | 19.44 B | 20.78 B | 20.09 B |
Revenue Actual | 18.34 B | 20.69 B | 20.75 B | 20.73 B |
Stock Performance
Shares of Johnson & Johnson were trading at $150.93 as of October 09. Over the last 52-week period, shares are up 14.44%. Given that these returns are generally positive, long-term shareholders are probably satisfied going into this earnings release.
Do not be surprised to see the stock move on comments made during its conference call. Johnson & Johnson is scheduled to hold the call at 08:30:00 ET and can be accessed here: https://edge.media-server.com/mmc/p/k7ozm2yc
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.